Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

NICE recommends roflumilast for COPD

In a final appraisal determination, NICE has approved roflumilast (Daxas) as an add-on to bronchodilator therapy for the treatment of severe COPD. Roflumilast...Read more

EC approves dimethyl fumarate for plaque psoriasis

The EC has approved a new oral formulation of dimethyl fumarate (Skilarence) for the treatment of moderate to severe plaque psoriasis in adults in need of...Read more

EMA recommends two new hepatitis C treatments

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of marketing authorisation for...Read more

New BNF app available to download

A new app that updates users with the latest information about medicines from the BNF and BNF for Children (BNFC) was made available on 26 June to download...Read more

Eluxadoline launched for IBS with diarrhoea

A new drug treatment for irritable bowel syndrome with diarrhoea (IBS-D), eluxadoline (Truberzi), has been launched in the UK. It is the first drug to be...Read more

Featured Articles

Diagnosis and management of rheumatoid arthritis
Early recognition and treatment of rheumatoid arthritis is the key to a more successful outcome. This article discusses the diagnosis of rheumatoid arthritis and its recommended management. 
Click here to view

The menopause: benefits and risks of available treatments
Menopausal symptoms affect many women, but debate continues over the role of hormone replacement therapy (HRT) in their management. This review provides a summary of the current treatment options for menopause management and considers their benefits and risks. 
Click here to view

The growing threat of nontuberculous mycobacteria
Nontuberculous mycobacteria (NTM) present a growing threat – a number of species are drug resistant and little is understood about how and where infection with these organisms occurs. A meeting organised by Papworth Hospital NHS Foundation Trust, and sponsored by Insmed Inc, was held in London in March to consider the state of the art in diagnosis and treatment of NTM pulmonary disease.
Click here to view

Web design and marketing agency Leamington Spa